SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000909518-13-000076
Filing Date
2013-02-14
Accepted
2013-02-14 17:06:28
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 mm02-1313opexa_sc13ga1.htm SC 13G/A 126371
2 JOINT FILING AGREEMENT mm02-1313opexa_sc13ga1exa.htm EX-99.A 12282
  Complete submission text file 0000909518-13-000076.txt   140433
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Subject) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81104 | Film No.: 13615659
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1271 AVENUE OF THE AMERICAS NEW YORK NY 10020
Business Address 1271 AVENUE OF THE AMERICAS NEW YORK NY 10020 646-285-9000
Lehman Brothers Holdings Inc. (Filed by) CIK: 0001568495 (see all company filings)

IRS No.: 133216325 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A